About Telix Pharmaceuticals
Telix Pharmaceuticals is a company based in Melbourne (Australia) founded in 2015. It operates as a Professional Services. Telix Pharmaceuticals has completed 9 acquisitions, including ANMI, ARTMS and ATLAB Pharma. Telix Pharmaceuticals offers products and services including Illuccix® and Gozellix®. Telix Pharmaceuticals operates in a competitive market with competitors including Advanced Accelerator Applications, SOFIE, ImaginAb, Mariana Oncology and AdvanCell, among others.
- Headquarter Melbourne, Australia
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Telix Pharmaceuticals Limited
-
Annual Revenue
$485.14 M (USD)55.85as on Dec 31, 2024
-
Net Profit
$30.92 M (USD)857.95as on Dec 31, 2024
-
EBITDA
$55.87 M (USD)54.36as on Dec 31, 2024
-
Latest Funding Round
$25 M (USD), Post-IPO
Nov 02, 2020
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
ANMI
& 8 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Telix Pharmaceuticals
Telix Pharmaceuticals is a publicly listed company on the ASX with ticker symbol TLX in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Telix Pharmaceuticals
Telix Pharmaceuticals offers a comprehensive portfolio of products and services, including Illuccix® and Gozellix®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Used for prostate cancer imaging in diagnostics.
Employed for prostate cancer imaging and diagnosis.
Unlock access to complete
Unlock access to complete
Funding Insights of Telix Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $25.0M
-
First Round
First Round
(02 Nov 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Post-IPO - Telix Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Telix Pharmaceuticals
Telix Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include China Grand Pharmaceutical and Healthcare. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finished formulations and APIs are manufactured for therapeutic categories.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Telix Pharmaceuticals
Telix Pharmaceuticals has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include ANMI, ARTMS and ATLAB Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Molecular imaging products and services are developed.
|
2018 | ||||
|
AI-driven clinical decision support for diagnosis and therapy planning
|
2017 | ||||
|
CDMO focused on synthesis of APIs
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Telix Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Telix Pharmaceuticals Comparisons
Competitors of Telix Pharmaceuticals
Telix Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Accelerator Applications, SOFIE, ImaginAb, Mariana Oncology and AdvanCell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of molecular imaging systems and radio-pharmaceuticals
|
|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Targeted radiopharmaceuticals for solid tumors are developed and pioneered.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceutical company developing targeted alpha therapies for cancer treatment
|
|
| domain | founded_year | HQ Location |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Telix Pharmaceuticals
Frequently Asked Questions about Telix Pharmaceuticals
When was Telix Pharmaceuticals founded?
Telix Pharmaceuticals was founded in 2015 and raised its 1st funding round 5 years after it was founded.
Where is Telix Pharmaceuticals located?
Telix Pharmaceuticals is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
What is the annual revenue of Telix Pharmaceuticals?
Annual revenue of Telix Pharmaceuticals is $485.14M as on Dec 31, 2024.
What does Telix Pharmaceuticals do?
Telix Pharmaceuticals is engaged in the development and commercialization of therapeutic and diagnostic radiopharmaceuticals, often referred to as theranostics. The companys extensive pipeline targets urologic oncology including prostate and kidney cancers, neuro-oncology such as glioma, musculoskeletal oncology like sarcoma, and bone marrow conditioning. Operations are supported by a robust global supply, manufacturing, and distribution network. Multiple clinical trials are conducted worldwide, with key products like Illuccix receiving regulatory approvals in various regions for prostate cancer imaging.
Who are the top competitors of Telix Pharmaceuticals?
Telix Pharmaceuticals's top competitors include Advanced Accelerator Applications, ImaginAb and SOFIE.
What products or services does Telix Pharmaceuticals offer?
Telix Pharmaceuticals offers Illuccix® and Gozellix®.
Is Telix Pharmaceuticals publicly traded?
Yes, Telix Pharmaceuticals is publicly traded on ASX under the ticker symbol TLX.
How many acquisitions has Telix Pharmaceuticals made?
Telix Pharmaceuticals has made 9 acquisitions, including ANMI, ARTMS, and ATLAB Pharma.
Who are Telix Pharmaceuticals's investors?
Telix Pharmaceuticals has 1 investor. Key investors include China Grand Pharmaceutical and Healthcare.
What is Telix Pharmaceuticals's ticker symbol?
The ticker symbol of Telix Pharmaceuticals is TLX on ASX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.